Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN196709 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Akt Murine Thymoma Viral Oncogene Homolog 1 (AKT1) (pSer473) antibody
- Antibody type
- Polyclonal
- Description
- Immunoaffinity Chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- pSer473
- Vial size
- 50 μL
- Storage
- Store the antibody (in aliquots) at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR).
Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.
Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
Baudhuin LM, Jiang Y, Zaslavsky A, Ishii I, Chun J, Xu Y
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004 Feb;18(2):341-3
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004 Feb;18(2):341-3
Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.
Feng J, Tamaskovic R, Yang Z, Brazil DP, Merlo A, Hess D, Hemmings BA
The Journal of biological chemistry 2004 Aug 20;279(34):35510-7
The Journal of biological chemistry 2004 Aug 20;279(34):35510-7
Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of Akt or protein kinase B and poor prognosis in acute myelogenous leukemia.
Min YH, Cheong JW, Kim JY, Eom JI, Lee ST, Hahn JS, Ko YW, Lee MH
Cancer research 2004 Aug 1;64(15):5225-31
Cancer research 2004 Aug 1;64(15):5225-31
No comments: Submit comment
No validations: Submit validation data